WebJun 7, 2024 · Cyclophosphamid. Cyclophosphamid is a prodrug which is converted in the body to the active metabolites. It acts at any stage of the cell cycle. It prevents cell division by cross-linking deoxyribonucleic acid (DNA) strands and reducing DNA synthesis. It also exerts a potent immunosuppressive effect. Cyclophosphamid is an antineoplastic in … WebSep 19, 2016 · Cyclophosphamide is an alkylating agent belonging to the group of oxazaphosporines. As cyclophosphamide is in clinical use for more than 40 years, there is a lot of experience using this drug for the treatment of cancer and as an immunosuppressive agent for the treatment of autoimmune and immune-mediated …
Toxoplasma gondii-derived antigen modifies tumor …
WebThis study aimed to establish an optimized animal model of chemotherapy-induced bone marrow suppression. After C57BL/6 mice were treated with intermediate- and high-dose (25/50 mg/kg) cyclophosphamide (CTX) for 10 days, the body-weight, changes in thymus and spleen, number of white blood cells (WBCs), red blood cells (RBCs), and platelets … WebWe describe the successful long-term treatment of three patients with severe autoimmune hepatitis with an immunosuppressive regimen consisting of cyclophosphamide and … pemberton cycling association
The effect of cyclophosphamide on the immune system: …
WebJul 22, 2024 · Cyclophosphamide can cause myelosuppression (leukopenia, neutropenia, thrombocytopenia and anemia), bone marrow failure, and severe immunosuppression … WebCyclophosphamide C7H15Cl2N2O2P CID 2907 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities ... pemberton chemical company